Pablo M. Garcia-Roves

🧬🔥 What if restoring NAD⁺ is not enough to reverse mitochondrial dysfunction and cellular aging? A new study in Nature Metabolism reveals an overlooked metabolic vulnerability: NADPH depletion can independently drive proliferation arrest and senescence-like phenotypes—even when the NADH/NAD⁺ ratio is normalized. The researchers introduce a genetically encoded bacterial NAD kinase, SaNADK, capable of expanding the mammalian NADP(H) pool and partially reversing aging-associated metabolic abnormalities. 🔬 1. Mitochondrial dysfunction creates two interconnected redox stresses Mitochondrial electron transport chain (ETC) inhibition causes: • NADH/NAD⁺ ↑ — NADH-reductive stress • NADPH/NADP⁺ ↓ — NADPH-oxidative stress These disturbances occur simultaneously but have distinct metabolic consequences. NADH accumulation impairs oxidative metabolism, while NADPH depletion disrupts reductive biosynthesis and cellular redox regulation. Importantly, restoring NAD⁺ recycling with pyruvate normalized NADH/NAD⁺ but failed to fully restore proliferation in several primary human fibroblast lines. Correcting one redox imbalance does not necessarily correct the other. ⚡ 2. A bacterial enzyme reveals the metabolic bottleneck The investigators expressed Escherichia coli soluble transhydrogenase (EcSTH) in mammalian cells. EcSTH catalyzes: NAD⁺ + NADPH → NADH + NADP⁺ This creates NADH-reductive stress and NADPH depletion without directly inhibiting the mitochondrial ETC. In primary human fibroblasts, EcSTH induced: • Proliferation arrest • Metabolic reprogramming • Reduced ATP availability • Altered nucleotide metabolism • Senescence-associated transcriptional changes Interestingly, pyruvate or α-ketobutyrate restored NADH/NAD⁺ balance but did not rescue proliferation. 🧠 3. Cancer cells and primary cells have different redox dependencies A striking comparison emerged between HeLa cancer cells and primary IMR-90 fibroblasts. HeLa cells: Proliferation could be rescued by restoring NAD⁺ recycling despite persistent NADPH depletion. Primary fibroblasts: Proliferation remained arrested until NADPH availability was restored. Stable isotope tracing revealed the underlying metabolic difference. HeLa cells relied more strongly on oxidative TCA cycle metabolism. Primary fibroblasts showed greater dependence on NADPH-driven reductive carboxylation. This suggests that metabolic vulnerabilities are determined not simply by mitochondrial activity but by how cells partition carbon flux between oxidative and reductive pathways. 🧬 4. SaNADK directly expands the NADP(H) pool The researchers engineered a constitutively active NAD kinase from Staphylococcus aureus. SaNADK catalyzes: NAD⁺ + ATP → NADP⁺ + ADP Endogenous metabolic enzymes subsequently reduce NADP⁺ to NADPH. SaNADK expression produced approximately: • 3-fold increase in NADP⁺ • 6-fold increase in NADPH • 6-fold expansion of the total NADP(H) pool Importantly, this occurred without exhausting the cellular NAD(H) pool. SaNADK restored proliferation in EcSTH-expressing fibroblasts, with additional improvement following pyruvate supplementation. 🔥 5. NADPH controls mitochondrial carbon flux—not merely antioxidant defense The study challenges the conventional interpretation of NADPH as primarily an antioxidant cofactor. In primary fibroblasts: NADPH → IDH1/IDH2-dependent reductive carboxylation → Citrate production Using [U-¹³C]glutamine tracing, the investigators distinguished: • Citrate M+4: Oxidative TCA metabolism • Citrate M+5: Reductive carboxylation EcSTH suppressed reductive carboxylation, whereas SaNADK restored the citrate M+5/M+4 ratio. Remarkably, conventional antioxidants—including N-acetylcysteine, vitamin C, vitamin E, and mitoTEMPO—failed to rescue proliferation. NADPH availability therefore supports metabolic functions that cannot be replaced by conventional ROS scavenging. ⚡ 6. A proposed metabolic safety valve protects mitochondrial function The investigators propose an intriguing mechanism. Under favorable redox conditions: NADPH availability ↑ → Reductive carboxylation ↑ → Excessive oxidative TCA flux ↓ → ETC electron overload ↓ This may preserve an appropriately oxidized coenzyme Q pool. Why does this matter? Mitochondrial dihydroorotate dehydrogenase (DHODH) requires oxidized CoQ for de novo pyrimidine biosynthesis. When the ETC becomes overloaded: NADH accumulation → Mitochondrial hyperpolarization → CoQ over-reduction → DHODH limitation → Pyrimidine biosynthesis impairment SaNADK partially restored mitochondrial membrane potential and de novo pyrimidine biosynthesis. This mechanism remains a proposed model requiring further causal validation. 🧪 7. NADPH restoration delays cellular senescence EcSTH-induced redox imbalance reproduced several features of mitochondrial dysfunction-associated senescence (MiDAS), including: • Increased CDKN1A/p21 and CDKN2B/p15 • Reduced LMNB1 and HMGB1 • Increased GDF15 • Altered senescence-associated secretory phenotype SaNADK expression delayed replicative senescence and increased resistance to oxidative stress induced by juglone. Importantly, the study did not establish that SaNADK reverses fully established senescence across cell types. 🫀 8. In vivo evidence: Reprogramming the aging liver The investigators delivered SaNADK to hepatocytes using AAV in aged male mice. After four weeks, liver transcriptomics revealed: 263 of 340 age-associated differentially expressed genes (77%) shifted in the opposite direction following SaNADK expression. Age-related transcriptional changes were negatively correlated with SaNADK-associated changes: Pearson r = −0.642; P = 7.60 × 10⁻⁴¹ The intervention attenuated transcriptional signatures associated with: • Inflammation and immune activation • Mitochondrial dysfunction • Oxidative phosphorylation • Lipid metabolic dysregulation Lipidomics also suggested partial restoration of age-depleted long-chain acylcarnitines and changes in sphingomyelin metabolism. However, improvements in hepatic fibrosis did not remain statistically significant after multiple-testing correction, and hepatic lipid accumulation was not significantly improved. 💊 9. Implications for therapeutic development These findings suggest a new direction for treating mitochondrial and age-associated metabolic disorders: NAD⁺ replenishment alone may be insufficient when NADPH-dependent metabolic functions remain impaired. Potential research strategies include: • Enhancing NADK1/NADK2 activity • Supporting NADPH-generating metabolic pathways • Developing tissue-selective NADP(H) restoration approaches • Combining NAD(H) and NADP(H) redox interventions • Identifying disease-specific NADPH dependencies using metabolomics and isotope tracing However, increasing NADPH is not universally beneficial. In some cancers, NADPH supports tumor growth, antioxidant defenses, and treatment resistance. ⚠️ 10. Important limitations The cellular studies relied heavily on genetically engineered redox perturbations. The in vivo experiments involved male mice, relatively small cohorts, and short-term hepatic gene expression. No lifespan extension, systemic rejuvenation, or clinical therapeutic efficacy was demonstrated. Furthermore, bacterial SaNADK is an experimental metabolic engineering tool—not an established therapeutic agent. 💡 The broader implication Aging and mitochondrial disease research has focused extensively on NAD⁺ depletion. This study suggests that NADPH availability, redox coupling, and metabolic flux directionality deserve equal attention. The key question may not simply be how much NAD⁺ a cell contains. It may be whether NAD(H) and NADP(H) pools are balanced sufficiently to sustain mitochondrial metabolism without excessive electron transport stress. The next frontier in mitochondrial therapeutics could be coordinated, tissue-specific restoration of NAD(H)–NADP(H) homeostasis. 📄 Pan X, Zuckerman AL, Miller KN, et al. Genetic modulation of NAD(P)H homeostasis reveals distinct redox-coupled metabolic vulnerabilities. Nature Metabolism. 2026. DOI: doi.org/10.1038/s42255-026-0… 📊 Open dataset: GEO GSE343929 #NADPH #NAD #Mitochondria #RedoxBiology #Aging #CellularSenescence #MetabolicReprogramming #NADKinase #SaNADK #MitochondrialDisease #Geroscience #DrugDiscovery

🧬 What if ageing is not simply a consequence of mitochondrial dysfunction—but a breakdown in communication between cellular organelles? A 2026 review in Nature Cell Biology by Mannino, Park & Wang proposes a broader framework for understanding ageing and longevity: Organelles are not merely metabolic factories. They are interconnected signalling hubs that coordinate cellular homeostasis, systemic metabolism and organismal longevity. 🔬 1. Lysosomes: Beyond cellular waste disposal Ageing disrupts lysosomal acidification, membrane integrity and degradative capacity, resulting in impaired proteostasis. However, lysosomes also coordinate longevity signalling through: AMPK–mTORC1–TFEB Lysosomal lipolysis and lipid-derived signalling ESCRT-mediated membrane repair In C. elegans, enhancing lysosomal lipolysis activates nuclear transcriptional programmes that extend lifespan. ⚡ 2. Mitochondria: More than ATP production Age-associated mitochondrial dysfunction involves reduced OXPHOS, declining NAD⁺, mtDNA damage and altered fission–fusion dynamics. Yet mitochondrial stress is not universally detrimental. Mild mitochondrial perturbations can activate protective programmes through: UPRmt NRF2/HSF1 ROS-dependent hormesis TCA metabolite–mediated epigenetic regulation The magnitude, timing and cellular context of mitochondrial stress determine whether adaptation or degeneration predominates. 🔗 3. Organelle contact sites: An emerging therapeutic frontier Mitochondria communicate directly with the endoplasmic reticulum and lysosomes. The ER–mitochondria interface coordinates calcium transfer through: IP3R → GRP75 → VDAC1 → MCU Excessive calcium transfer can promote cellular senescence, while disrupted contacts compromise mitochondrial homeostasis. Meanwhile, mitochondria–lysosome contacts regulate calcium, lipid exchange and mitochondrial dynamics through RAB7-dependent mechanisms. These findings suggest that restoring organelle communication—not simply increasing mitochondrial activity—could represent a therapeutic strategy. 🌍 4. Ageing is also a systemic communication problem Organelle stress in one tissue can influence distant organs. Examples include: Muscle mitochondrial stress → GDF15 → adipose/liver metabolic adaptation Muscle mitochondrial dysfunction → FGF21 → systemic metabolic remodelling Neuronal mitochondrial stress → Wnt signalling → intestinal UPRmt Lysosomal lipid signalling → neuronal responses → longevity regulation Remarkably, organelle-dependent signals can also influence epigenetic inheritance across generations in C. elegans. 💊 5. Implications for longevity therapeutics Rapamycin, metformin, dietary restriction, exercise and mitophagy-promoting interventions converge on overlapping organelle networks. Their benefits may involve coordinated improvements in: Lysosomal function + mitochondrial quality control + ER proteostasis + inter-organelle communication. These mechanisms are supported largely by experimental models; extending lifespan in humans remains unproven for most pharmacological interventions. 💡 The central insight: Perhaps the next generation of gerotherapeutics should move beyond targeting individual organelles toward restoring the integrated organelle network. For sarcopenia, metabolic disease and neurodegeneration, the crucial question may be not only whether mitochondria are dysfunctional, but whether mitochondria, lysosomes and the ER can still communicate effectively. Healthy ageing may depend as much on organelle coordination as on organelle function. 📄 Mannino P, Park M, Wang MC. Organellar insights in ageing and longevity. Nature Cell Biology. 2026;28:861–874. DOI: doi.org/10.1038/s41556-026-0… #Aging #Longevity #Geroscience #Mitochondria #Lysosomes #Autophagy #Mitophagy #Sarcopenia #Metabolism #CellBiology